HPV screening kit utilizing PNA probe technology for detection and genotyping of human papillomavirus in clinical samples. Designed for cervical cancer risk stratification and screening programs in diagnostic laboratories.
Manufactured by
Daejeon, South Korea
PANAGENE will always make its best efforts to develop innovative platform technologies and strive to be a global leader in the field of molecular diagnostics. We, PANAGENE Inc. have been developing and launching accurate and convenient in vitro diagnostic products consistently from Oncology to Infectious Diseases. We exercise strict quality management policy and make efforts to meet global standards and appropriate regulations for our IVD products. PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy. Our advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories. (EGFR, KRAS, NRAS, BRAF, PIK3CA, IDH1, IDH2, JAK2, BCR-ABL, c-KIT, TERT, EML4-ALK, ROS1) Also we apply our platform technology to maximize multiplex capability to detect using melting curve analysis with high-level performance. (HPV, STD, CRE, TB/NTM) Lastly, we have our automation extraction system to use with molecular diagnostics kits to provide full package solution for the user. The extraction machine is 100% in house developed and optimized with our kits. During this Pandemic, we are providing the machines and extraction kits to reach out who needs the testings. (Viral, FFPE, cfDNA extraction kits) PANAGENE is pursuing open innovation and seeking opportunity for collaboration with various organizations including pharmaceutical and diagnostics companies. We always welcome organizations who are interest in our technologies and/or products. We will do our best for customer satisfaction and for realizing our vision, “Platform Technology Provider”.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Advanced Molecular Diagnostics Ltd.
United Kingdom · 3 relevant products
Bioperfectus
China · 2 relevant products
Access Bio, Inc.
United States · 1 relevant product
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 10 relevant products
APPOLON BIOTECK SAS
France · 1 relevant product
SeeGene Middle East FZE
South Korea · 3 relevant products
Guangzhou LBP Medicine Science & Technology Co.,Ltd.
China · 1 relevant product
FIRSTLAB
Brazil · 1 relevant product
HOLOGIC
China · 2 relevant products
Shanghai FLY Medical Devices Co., Ltd.
China · 2 relevant products
44 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 106 closest product alternatives
Advanced Molecular Diagnostics Ltd. · United Kingdom
Real-time PCR assay for high-risk HPV detection and screening. Supports cervical cancer prevention through HPV risk assessment.
Bioperfectus · China
Comprehensive screening system for human papillomavirus detection and cervical cancer risk assessment. Integrates nucleic acid extraction, PCR instrumentation, and analysis workflows for clinical laboratory use.
Bioperfectus · China
Integrated system for HPV detection and cervical cancer screening utilizing nucleic acid extraction and PCR-based analysis. Provides accurate identification of high-risk HPV strains to enable early cervical cancer detection and prevention.
Access Bio, Inc. · United States
Molecular test for human papillomavirus detection and screening. PCR-based detection for cervical cancer risk assessment.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
HPV genotyping system for cervical cancer screening that identifies high-risk human papillomavirus types to improve diagnostic accuracy and patient risk stratification. Fully automated nucleic acid extraction and analysis platform designed for clinical laboratory integration.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Single tube HPV detection kit for cervical cancer screening identifying 14 high-risk HPV types. Designed to satisfy cervical cytology screening requirements.
APPOLON BIOTECK SAS · France
A molecular diagnostic test kit for HPV screening recommended by the CNR Papillomavirus for cervical cancer detection. The test has been validated through rigorous clinical studies demonstrating sensitivity, specificity, and compliance with international standards.
SeeGene Middle East FZE · South Korea
High multiplex HPV detection assays designed for cervical cancer screening programs. These tests provide accurate human papillomavirus identification to support cervical cancer prevention strategies.
Guangzhou LBP Medicine Science & Technology Co.,Ltd. · China
Liquid-based cytology kit combined with HPV detection for cervical cancer screening. The system integrates morphological assessment with molecular HPV testing for comprehensive cervical dysplasia evaluation.
FIRSTLAB · Brazil
Laboratory test for human papillomavirus detection in cervical specimens. Essential for preventive cancer screening protocols.
HOLOGIC · China
HPV and cytology-based testing systems for early detection of cervical cancer and precancerous lesions.
Shanghai FLY Medical Devices Co., Ltd. · China
A diagnostic test designed to detect human papillomavirus (HPV) infection, which is a major cause of cervical cancer in women. The test identifies high-risk HPV types that can lead to cervical cancer development. Early detection through HPV testing enables timely intervention and prevention of cervical cancer progression. This screening tool is particularly important for women's health as cervical cancer is preventable and treatable when detected early.
94 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products